Osteoarthritis Pain Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064037
  • May 2021
  • Pharmaceuticals
  • 139 Pages
The Osteoarthritis Pain Drugs Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Sanofi, Horizon Therapeutics PLC, Johnson & Johnson, GlaxoSmithKline PLC, Bayer AG, Abbott, Pfizer, Inc., Eli Lilly, Anika Therapeutics, Inc., Novartis AG, Ferring Pharmaceuticals, Bioventus, Zimmer Biomet Holdings, Inc., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Osteoarthritis Pain Drugs market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Osteoarthritis Pain Drugs market is expected to attain Pre COVID-19 levels by mid-2022.

Osteoarthritis Pain Drugs Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Osteoarthritis Pain Drugs market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Osteoarthritis Pain Drugs Market Competitive and Premeditated Analysis
In the Osteoarthritis Pain Drugs report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Osteoarthritis Pain Drugs research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Osteoarthritis Pain Drugs Market:
The Osteoarthritis Pain Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Sanofi, Horizon Therapeutics PLC, Johnson & Johnson, GlaxoSmithKline PLC, Bayer AG, Abbott, Pfizer, Inc., Eli Lilly, Anika Therapeutics, Inc., Novartis AG, Ferring Pharmaceuticals, Bioventus, Zimmer Biomet Holdings, Inc., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc.

The Osteoarthritis Pain Drugs market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Osteoarthritis Pain Drugs Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Osteoarthritis Pain Drugs market:
By Drugs
NSAIDs
Analgesics
Viscosupplements
Corticosteroids
Others
Route of Administration
Oral
Parenteral
Topical
Dosage Form
Solid
Liquid
Semi-solid
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Analysis of the Osteoarthritis Pain Drugs market:
The Osteoarthritis Pain Drugs market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Osteoarthritis Pain Drugs report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Osteoarthritis Pain Drugs market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Osteoarthritis Pain Drugs market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Osteoarthritis Pain Drugs market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Osteoarthritis Pain Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Osteoarthritis Pain Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Osteoarthritis Pain Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Osteoarthritis Pain Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Osteoarthritis Pain Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Sanofi
  • Horizon Therapeutics PLC
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Bayer AG
  • Abbott
  • Pfizer, Inc.
  • Eli Lilly
  • Anika Therapeutics, Inc.
  • Novartis AG
  • Ferring Pharmaceuticals
  • Bioventus
  • Zimmer Biomet Holdings, Inc.
  • Fidia Farmaceutici s.p.a.
  • Flexion Therapeutics, Inc.
  • NSAIDs
  • Analgesics
  • Viscosupplements
  • Corticosteroids
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Osteoarthritis Pain Drugs Market Snapshot
          2.1.1. Global Osteoarthritis Pain Drugs Market By Drugs,2019
               2.1.1.1.NSAIDs
               2.1.1.2.Analgesics
               2.1.1.3.Viscosupplements
               2.1.1.4.Corticosteroids
               2.1.1.5.Others
          2.1.2. Global Osteoarthritis Pain Drugs Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Osteoarthritis Pain Drugs Market By End-use,2019
          2.1.4. Global Osteoarthritis Pain Drugs Market By Geography,2019

3. Global Osteoarthritis Pain Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drugs, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drugs, 2020
     4.2. Global Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028

5. Global Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Osteoarthritis Pain Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Osteoarthritis Pain Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Osteoarthritis Pain Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028
          7.2.3. North America Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Osteoarthritis Pain Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Osteoarthritis Pain Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028
          7.3.3. Europe Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Osteoarthritis Pain Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Osteoarthritis Pain Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028
          7.4.3. Asia Pacific Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Osteoarthritis Pain Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Osteoarthritis Pain Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028
          7.5.3. Latin America Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Osteoarthritis Pain Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Osteoarthritis Pain Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Osteoarthritis Pain Drugs Market Size (US$), By Drugs, 2018 – 2028
          7.6.3. MEA Osteoarthritis Pain Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Osteoarthritis Pain Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Osteoarthritis Pain Drugs Providers
        8.4.1 Sanofi
                8.4.1.1 Business Description
                8.4.1.2 Sanofi Geographic Operations
                8.4.1.3 Sanofi Financial Information
                8.4.1.4 Sanofi Product Positions/Portfolio
                8.4.1.5 Sanofi Key Developments
        8.4.2 Horizon Therapeutics PLC
                8.4.2.1 Business Description
                8.4.2.2 Horizon Therapeutics PLC Geographic Operations
                8.4.2.3 Horizon Therapeutics PLC Financial Information
                8.4.2.4 Horizon Therapeutics PLC Product Positions/Portfolio
                8.4.2.5 Horizon Therapeutics PLC Key Developments
        8.4.3 Johnson & Johnson
                8.4.3.1 Business Description
                8.4.3.2 Johnson & Johnson Geographic Operations
                8.4.3.3 Johnson & Johnson Financial Information
                8.4.3.4 Johnson & Johnson Product Positions/Portfolio
                8.4.3.5 Johnson & Johnson Key Developments
        8.4.4 GlaxoSmithKline PLC
                8.4.4.1 Business Description
                8.4.4.2 GlaxoSmithKline PLC Geographic Operations
                8.4.4.3 GlaxoSmithKline PLC Financial Information
                8.4.4.4 GlaxoSmithKline PLC Product Positions/Portfolio
                8.4.4.5 GlaxoSmithKline PLC Key Developments
        8.4.5 Bayer AG
                8.4.5.1 Business Description
                8.4.5.2 Bayer AG Geographic Operations
                8.4.5.3 Bayer AG Financial Information
                8.4.5.4 Bayer AG Product Positions/Portfolio
                8.4.5.5 Bayer AG Key Developments
        8.4.6 Abbott
                8.4.6.1 Business Description
                8.4.6.2 Abbott Geographic Operations
                8.4.6.3 Abbott Financial Information
                8.4.6.4 Abbott Product Positions/Portfolio
                8.4.6.5 Abbott Key Developments
        8.4.7 Pfizer, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Pfizer, Inc. Geographic Operations
                8.4.7.3 Pfizer, Inc. Financial Information
                8.4.7.4 Pfizer, Inc. Product Positions/Portfolio
                8.4.7.5 Pfizer, Inc. Key Developments
        8.4.8 Eli Lilly
                8.4.8.1 Business Description
                8.4.8.2 Eli Lilly Geographic Operations
                8.4.8.3 Eli Lilly Financial Information
                8.4.8.4 Eli Lilly Product Positions/Portfolio
                8.4.8.5 Eli Lilly Key Developments
        8.4.9 Anika Therapeutics, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Anika Therapeutics, Inc. Geographic Operations
                8.4.9.3 Anika Therapeutics, Inc. Financial Information
                8.4.9.4 Anika Therapeutics, Inc. Product Positions/Portfolio
                8.4.9.5 Anika Therapeutics, Inc. Key Developments
        8.4.10 Novartis AG
                8.4.10.1 Business Description
                8.4.10.2 Novartis AG Geographic Operations
                8.4.10.3 Novartis AG Financial Information
                8.4.10.4 Novartis AG Product Positions/Portfolio
                8.4.10.5 Novartis AG Key Developments
        8.4.11 Ferring Pharmaceuticals
                8.4.11.1 Business Description
                8.4.11.2 Ferring Pharmaceuticals Geographic Operations
                8.4.11.3 Ferring Pharmaceuticals Financial Information
                8.4.11.4 Ferring Pharmaceuticals Product Positions/Portfolio
                8.4.11.5 Ferring Pharmaceuticals Key Developments
        8.4.12 Bioventus
                8.4.12.1 Business Description
                8.4.12.2 Bioventus Geographic Operations
                8.4.12.3 Bioventus Financial Information
                8.4.12.4 Bioventus Product Positions/Portfolio
                8.4.12.5 Bioventus Key Developments
        8.4.13 Zimmer Biomet Holdings, Inc.
                8.4.13.1 Business Description
                8.4.13.2 Zimmer Biomet Holdings, Inc. Geographic Operations
                8.4.13.3 Zimmer Biomet Holdings, Inc. Financial Information
                8.4.13.4 Zimmer Biomet Holdings, Inc. Product Positions/Portfolio
                8.4.13.5 Zimmer Biomet Holdings, Inc. Key Developments
        8.4.14 Fidia Farmaceutici s.p.a.
                8.4.14.1 Business Description
                8.4.14.2 Fidia Farmaceutici s.p.a. Geographic Operations
                8.4.14.3 Fidia Farmaceutici s.p.a. Financial Information
                8.4.14.4 Fidia Farmaceutici s.p.a. Product Positions/Portfolio
                8.4.14.5 Fidia Farmaceutici s.p.a. Key Developments
        8.4.15 Flexion Therapeutics, Inc.
                8.4.15.1 Business Description
                8.4.15.2 Flexion Therapeutics, Inc. Geographic Operations
                8.4.15.3 Flexion Therapeutics, Inc. Financial Information
                8.4.15.4 Flexion Therapeutics, Inc. Product Positions/Portfolio
                8.4.15.5 Flexion Therapeutics, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Osteoarthritis Pain Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Osteoarthritis Pain Drugs Market Revenue, By Drugs, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Osteoarthritis Pain Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Osteoarthritis Pain Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Osteoarthritis Pain Drugs Market Revenue, By Drugs, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Osteoarthritis Pain Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Osteoarthritis Pain Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Osteoarthritis Pain Drugs Market Revenue, By Drugs, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Osteoarthritis Pain Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Osteoarthritis Pain Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Osteoarthritis Pain Drugs Market Revenue, By Drugs, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Osteoarthritis Pain Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Osteoarthritis Pain Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Osteoarthritis Pain Drugs Market Revenue, By Drugs, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Osteoarthritis Pain Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Osteoarthritis Pain Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Osteoarthritis Pain Drugs: Market Segmentation 
FIG. 2 Global Osteoarthritis Pain Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Osteoarthritis Pain Drugs Market, By Drugs, 2019 (US$ Mn) 
FIG. 5 Global Osteoarthritis Pain Drugs Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Osteoarthritis Pain Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Osteoarthritis Pain Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Osteoarthritis Pain Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Osteoarthritis Pain Drugs Providers, 2019
FIG. 11 Global Osteoarthritis Pain Drugs Market Revenue Contribution, By Drugs, 2019 & 2028 (Value %) 
FIG. 12 Global Osteoarthritis Pain Drugs Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Osteoarthritis Pain Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Osteoarthritis Pain Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Osteoarthritis Pain Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Osteoarthritis Pain Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Osteoarthritis Pain Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Osteoarthritis Pain Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Osteoarthritis Pain Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Osteoarthritis Pain Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Osteoarthritis Pain Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Osteoarthritis Pain Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Osteoarthritis Pain Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Osteoarthritis Pain Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Osteoarthritis Pain Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Osteoarthritis Pain Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Pain Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Pain Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Pain Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Osteoarthritis Pain Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Osteoarthritis Pain Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Osteoarthritis Pain Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Osteoarthritis Pain Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Osteoarthritis Pain Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Osteoarthritis Pain Drugs Market Value, By Country, 2018 – 2028
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Horizon Therapeutics PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Anika Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ferring Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bioventus: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zimmer Biomet Holdings, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Fidia Farmaceutici s.p.a.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Flexion Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Osteoarthritis Pain Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Osteoarthritis Pain Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Pain Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Pain Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Pain Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Osteoarthritis Pain Drugs Providers, 2016
FIG.  Global Osteoarthritis Pain Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Analgesics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Viscosupplements Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Corticosteroids Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Osteoarthritis Pain Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Osteoarthritis Pain Drugs Market Value, 2018 – 2028, (US$ Mn)